Regulatory Considerations for Microbiome Based Therapeutics

Time: 11:30 am
day: Conference Day One Track C AM 1


  • An overview of CMC requirements for Live Biotherapeutic Products
  • Discussion of assays for product characterization and release
  • Presentation of proof of principle study assessing the use of MALDI-TOF for single strain enumeration from multi-strain mixtures